VD

Vinayak Dinesh Dendukuri

Active Director Whole-Time Director DIN 07601309
DIN 07601309 First appointment Sep 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 5 historical roles
Total affiliations 9 Since Sep 2016
Shareholding value •••• Premium profile

About Vinayak Dinesh Dendukuri

Data last updated:

Vinayak Dinesh Dendukuri is a Whole-Time Director at Bafna Pharmaceuticals Limited (since 2023), Director at Novick Bio-Sciences Private Limited (since 2016) and Director at Beltree Lifesciences India Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma, Packaging and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹163 Cr; the largest is Bafna Pharmaceuticals Limited at ₹149 Cr (FY 2025). Earlier, Vinayak Dinesh Dendukuri was a Director at Brane Services Private Limited (2020–2023) and Director at Brane Products Private Limited (2020–2023) and 3 more.

DIN 07601309
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 19 Sep 2016
Oldest Company Age 31 yrs
Largest company Bafna Pharmaceuticals Limited · ₹149 Cr (FY 2025)
Combined revenue ₹163 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bafna Pharmaceuticals Limited L24294TN1995PLC030698
Whole-Time Director26 Jun 20231995₹149 Cr (FY 2025)Active
Novick Bio-Sciences Private Limited U74999TG2016PTC112022
Director19 Sep 20162016₹14.34 Cr (FY 2024)Active
Director27 Mar 20232022₹9.5 Lakh (FY 2023)Active
Designated Partner14 Feb 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brane Services Private Limited U72900TG2020PTC142592
Director07 Aug 20202020₹1.97 Cr (FY 2023)Active
Brane Products Private Limited U72900TG2020PTC142505
Director04 Aug 20202020₹88.7 Lakh (FY 2023)Active
Brane Enterprises Private Limited U72900TG2020PTC141392
Director06 Jul 20202020₹47.50 Cr (FY 2023)Active
Director03 Sep 20192015Converted To Llp
Rasina Therapeuctics Private Limited U24230TG2019PTC134362
Nominee Director25 Jul 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rasina Therapeuctics Private Limited
Novick Bio-Sciences Private Limited
Sirius Unify Ventures Llp
Beltree Lifesciences India Private Limited
Premium access

Shareholding and investment profile for Vinayak Dinesh Dendukuri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinayak Dinesh Dendukuri

Vinayak Dinesh Dendukuri currently holds 4 directorships: Bafna Pharmaceuticals Limited (Whole-Time Director, since 26 Jun 2023, revenue ₹149 Cr (FY 2025)); Novick Bio-Sciences Private Limited (Director, since 19 Sep 2016, revenue ₹14.34 Cr (FY 2024)); Beltree Lifesciences India Private Limited (Director, since 27 Mar 2023, revenue ₹9.5 Lakh (FY 2023)); Sirius Unify Ventures Llp (Designated Partner, since 14 Feb 2025).

Vinayak Dinesh Dendukuri was first appointed on 19 Sep 2016 as Director at Novick Bio-Sciences Private Limited. The most recent appointment on record is 14 Feb 2025 at Sirius Unify Ventures Llp.

The 3 current companies of Vinayak Dinesh Dendukuri that report revenue have a combined latest revenue of ₹163 Cr: Bafna Pharmaceuticals Limited ₹149 Cr (FY 2025); Novick Bio-Sciences Private Limited ₹14.34 Cr (FY 2024); Beltree Lifesciences India Private Limited ₹9.5 Lakh (FY 2023).

Vinayak Dinesh Dendukuri held 5 earlier board appointments: Brane Services Private Limited (Director, 07 Aug 2020 to 20 Jul 2023); Brane Products Private Limited (Director, 04 Aug 2020 to 20 Jul 2023); Brane Enterprises Private Limited (Director, 06 Jul 2020 to 20 Jul 2023); Next-Spaces Ecobuild India Private Limited (Director, 03 Sep 2019 to 15 Dec 2019); Rasina Therapeuctics Private Limited (Nominee Director, from 25 Jul 2019).

The current boards of Vinayak Dinesh Dendukuri's companies include Akila Chintalapati Raju (Bafna Pharmaceuticals Limited), Ashok Barathi Mohanachandran (Bafna Pharmaceuticals Limited), Bafna Mahaveer Chand (Bafna Pharmaceuticals Limited), Melagiri Sridhar (Bafna Pharmaceuticals Limited), Palamadai Krishnan Sundaresan (Bafna Pharmaceuticals Limited), Ravichandran Chitra (Bafna Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available